Đang chuẩn bị liên kết để tải về tài liệu:
Identification of a novel S6K1 inhibitor, rosmarinic acid methyl ester, for treating cisplatin-resistant cervical cancer

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

The mTOR/S6K1 signaling pathway is often activated in cervical cancer, and thus considered a molecular target for cervical cancer therapies. Inhibiting mTOR is cytotoxic to cervical cancer cells and creates a synergistic anti-tumor effect with conventional chemotherapy agents. | Identification of a novel S6K1 inhibitor rosmarinic acid methyl ester for treating cisplatin-resistant cervical cancer

TÀI LIỆU LIÊN QUAN

Molecular cytogenetic identification of a novel hexaploid wheat–Thinopyrum intermedium partial amphiploid with high protein content

PGA: An R/Bioconductor package for identification of novel peptides using a customized database derived from RNA-Seq

A novel scan statistics approach for clustering identification and comparison in binary genomic data

Parallel identification of novel antimicrobial peptide sequences from multiple anuran species by targeted DNA sequencing

Reduced translation efficiency due to novel splicing variants in 5′ untranslated region and identification of novel cis-regulatory elements in canine and human BRCA2

Identification of a novel subgroup of endometrial cancer patients with loss of thyroid hormone receptor beta expression and improved survival

Identification of novel loci associated with maturity and yield traits in early maturity soybean plant introduction lines

Identification of PLA2G7 as a novel biomarker of diffuse large B cell lymphoma

Identification of novel diagnostic biomarkers in endometrial cancer using targeted metabolomic profiling

Báo cáo y học: " Identification of novel conserved functional motifs across most Influenza A viral strains"